StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SZLS.WT warrants could go to 0.075 ¢ next week $$$$$$$$$$$$$

<< Previous

Bullboard Posts

Next >>

Comment by skier59on Dec 18, 2020 2:13pm

128 Views

Post# 32141378

RE:RE:SZLS.WT warrants could go to 0.075 ¢ next week $$$$$$$$$$$$$

Couldn't help myself, just got another 40,000 warrants. They just look so yummy at these prices. Bought 120,000 warrants the past 2 days :)

That's $1.12 @ break-even. Locks me in 15,000 future shares. But they also might make a nice trade in a couple of months?

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland